Skip to main content

Bravo for Puerto Rico!

This photo comes from New York Channel 1. Sorry for the quality. This is some of Puerto Rican leadership announcing an end to the political impasse that has left nearly 100,000 people out of work.

Puerto Rican Governor Anibal Acevedo Vila and the Puerto Rican legislature appear to have reached an agreement that will have government workers back on the job Monday morning. Thank God!

I hope that whatever lead to the shutdown in the first place continues to heal, both for the Puerto Rican people, but also because whatever happens in Puerto Rico has a direct impact on the battle for a cure for Hermansky-Pudlak Syndrome. Fact is the syndrome is most common on the island of Puerto Rico, and thus if things are not going well there, the odds of being able to do outreach and get people to travel to Washington to participate in research to find treatments is hindered.

We are in a race to fill this Phase III trial for a treatment for the pulmonary fibrosis of HPS. Getting potential patients to the National Institutes of Health to be screened is a challenge. First you’ve got to find them. Then you’ve got to impress upon them how important this research is, and what it could mean to them and their families. Often people with HPS are completely unaware the disorder could be affecting their lungs. In the early stages it’s easy to pass off the symptoms as asthma, allergies, or just getting out of shape.

And if we manage to get them to the NIH to be screened, they must have lung function scores within a certain range and have no other serious medical conditions that could exempt them. So far we only have nine people in the trial, and we must have 40 to continue. The clock is ticking. Failure to fill the trial could result in losing the funding. It would also set us back years as suddenly the researchers would be skeptical about our ability to fill any future trials. Failure is simply not an option.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria